Literature DB >> 8070507

Site-dependent small intestinal absorption of ranitidine.

T Gramatté1, E el Desoky, U Klotz.   

Abstract

The site-dependent, small intestinal absorption characteristics of ranitidine were estimated by the intestinal steady state perfusion technique (triple lumen tubing system) combined with simultaneous measurement of serum concentrations of ranitidine. Ranitidine 150 mg.l-1 was perfused at 10 ml.min-1 for 180 min in different sites of the small intestine between 65-250 cm beyond the teeth. Each of 9 healthy, male volunteers was examined twice, using perfusion sites in different regions of the small intestine to permit intraindividual comparisons. The absorption rates (micrograms.30 cm-1.min-1) calculated from intestinal samples showed distinct site-dependence; the highest rates (medians 160-923 micrograms.30 cm-1.min-1) were found in the most proximal region (duodenojejunal junction), and the most distal perfusion sites (distal jejunum/ileum) showed median rates from 193 to 265 micrograms.30 cm-1.min-1. In both of these regions there was a significant positive correlation between the net intestinal water flux and the movement of ranitidine. Within the mid-jejunum, every subject showed marked secretion of ranitidine into the gut lumen (medians -338 to -124 micrograms.30 cm-1.min-1), and in this region there was no influence of water flux on ranitidine movement. The intraluminal results were confirmed by the corresponding site-dependent areas under the serum concentration-time curves (AUC), which decreased with the distance of the perfusion site from the teeth. After the more distal perfusions individual AUCs amounted to 64-16% of the AUCs obtained after more proximal applications. The results demonstrate the small intestine as the site of a gradient of absorption of ranitidine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070507     DOI: 10.1007/bf00192558

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  29 in total

1.  Studies of intestinal digestion and absorption in the human.

Authors:  B BORGSTROM; A DAHLQVIST; G LUNDH; J SJOVALL
Journal:  J Clin Invest       Date:  1957-10       Impact factor: 14.808

2.  Passive movement of water and sodium across the human small intestinal mucosa.

Authors:  K H Soergel; G E Whalen; J A Harris
Journal:  J Appl Physiol       Date:  1968-01       Impact factor: 3.531

3.  An evaluation of perfusion techniques in the study of water and electrolyte absorption in man: the problem of endogenous secretions.

Authors:  G E Sladen; A M Dawson
Journal:  Gut       Date:  1968-10       Impact factor: 23.059

4.  Absorption of glucose, sodium, and water by the human jejunum studied by intestinal perfusion with a proximal occluding balloon and at variable flow rates.

Authors:  R Modigliani; J J Bernier
Journal:  Gut       Date:  1971-03       Impact factor: 23.059

Review 5.  Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.

Authors:  J G Riddell; D W Harron; R G Shanks
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

6.  Active chloride secretion in the normal human jejunum.

Authors:  G R Davis; C A Santa Ana; S Morawski; J S Fordtran
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

7.  Intestinal secretion of erythromycin base.

Authors:  D R Holland; J F Quay
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

8.  Effects of olsalazine and sulphasalazine on jejunal and ileal water and electrolyte absorption in normal human subjects.

Authors:  A H Raimundo; D H Patil; P G Frost; D B Silk
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

Review 9.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part I).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

10.  Influence of digestive secretions and food on intestinal absorption of nicardipine.

Authors:  J C Delchier; M Guerret; N Vidon; C Dubray; D Lavene
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more
  22 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine.

Authors:  Ophelia Q P Yin; Brian Tomlinson; Albert H L Chow; Moses S S Chow
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 3.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

Review 4.  Impact of osmotically active excipients on bioavailability and bioequivalence of BCS class III drugs.

Authors:  Mei-Ling Chen; Nakissa Sadrieh; Lawrence Yu
Journal:  AAPS J       Date:  2013-07-19       Impact factor: 4.009

5.  Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice.

Authors:  Dilara Jappar; Yongjun Hu; David E Smith
Journal:  Drug Metab Dispos       Date:  2011-08-31       Impact factor: 3.922

6.  Use of the InteliSite capsule to study ranitidine absorption from various sites within the human intestinal tract.

Authors:  Y K Pithavala; W D Heizer; A F Parr; R L O'Connor-Semmes; K L Brouwer
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

7.  Applications and simulations of a discontinuous oral absorption pharmacokinetic model.

Authors:  J W Witcher; F D Boudinot
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

8.  Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine.

Authors:  Abdul W Basit; Fridrun Podczeck; J Michael Newton; Wendy A Waddington; Peter J Ell; Larry F Lacey
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 9.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

10.  Effect of pancreatico-biliary secretions and GI transit time on the absorption and pharmacokinetic profile of ranitidine in humans.

Authors:  K S Reynolds; M H Song; W D Heizer; C B Burns; D A Sica; K L Brouwer
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.